Skip to main content
Veterinary Medicines

Kaopectate, suspensie voor oraal gebruik

Not authorised
  • KAOLIN, LIGHT
  • PECTIN

Product identification

Medicine name:
Kaopectate, suspensie voor oraal gebruik
Active substance:
  • KAOLIN, LIGHT
  • PECTIN
Target species:
  • Cattle (calf)
  • Sheep (lamb)
  • Pig (piglet)
  • Horse (foal)
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • KAOLIN, LIGHT
    197.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • PECTIN
    4.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle (calf)
      • Meat and offal
        no withdrawal period
      • Meat and offal
        no withdrawal period
    • Sheep (lamb)
      • Meat and offal
        no withdrawal period
    • Pig (piglet)
      • Meat and offal
        no withdrawal period
    • Horse (foal)
      • Meat and offal
        no withdrawal period
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA07BC30
Authorisation status:
  • Surrendered
Authorised in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Purna Pharmaceuticals
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 3045
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 24/10/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."